The End Rheumatic Heart Disease Centre of Research Excellence (END RHD CRE) was funded by the National Health and Medical Research Council in 2014.
Working as part of a national collaboration, the END RHD CRE has produced a costed, step-wise strategy to end rheumatic heart disease (RHD) as a public health priority in Australia.
The END RHD CRE is the first time that any country has had an opportunity to build a comprehensive, evidence based strategy for ending rheumatic heart disease. The strategy includes an 11-year plan to achieve disease control by 2031, reducing the incidence of acute rheumatic fever and bringing the prevalence of RHD for Aboriginal and Torres Strait Islander Australians down to the same level as non-Aboriginal Australians. This project represents a tremendous challenge and an untold opportunity to ‘close the gap’ and end the disparity for our Aboriginal communities.
Collaborating Institutions
Investigators
Chief Investigators
Professor Jonathan Carapetis AM
Professor Dawn Bessarab
Professor Alex Brown
Professor Bart Currie
Ms Heather D’Antoine
Professor Nick de Klerk
Dr Dan McAullay
Professor Graeme Maguire
Associate Professor Anna Ralph
Associate Professor Andrew Steer
Associate Investigators
Professor David Atkinson
Dr Samantha Colquhoun
Associate Professor Vicki Krause
Professor Christopher Reid
Professor Thomas Snelling
Dr Stephanie Trust
Dr Gavin Wheaton
Dr Rosemary Wyber
Advocacy: END RHD
We want our research to be actively translated into policies and programs that make a difference - not just eliminating rheumatic heart disease, but significantly helping to close the health gap for Aboriginal and Torres Strait Islander Australians.
We're proud to be a founding member of END RHD, a national alliance of organisations amplifying the voices of those most at-risk, and advocating for urgent, comprehensive action to tackle RHD in Australia.
Visit the END RHD website to learn more about how you can get involved.